https://bswhealth.webex.com/bswhealth/j.php?MTID=me02ba9c7b263a1e805ee53056f0e2d47

OBJECTIVES: As a result of this activity, the participant should be able to: 

1. Describe recent medical treatment advancements for patients with Cystic Fibrosis and how this has impacted both longevity and quality of life.
2. Explain Psychosocial issues unique to this population and how these issues may impact patients' psychological functioning.
3. Identify the role of psychologist in CF treatment team and be aware of existing CF Foundation mental health treatment guidelines.

FACULTY DISCLOSURE: Chelsea A. Werchan, PhD has a financial relationship with Cystic Fibrosis Foundation as an Advisory Board Member/Authorship. 

PLANNERS DISCLOSURES:  James Bourgeois, MD, Louis A. Gamino, PhD, ABP, FT, Radha K. Kambhampati, MD, and Virginia M. Flores, MD do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.